Long-term outcome of patients with mild intermittent claudication under secondary prevention

Vasa - Journal of Vascular Diseases

Volumn 38, Issue 4, 2009, Pages 346-355

  Taute, Bettina Maria ^a   Thommes, S ^a   Taute, R ^a   Rapmund, I ^a   Lindner, K ^a   Podhaisky, H ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Cancer; Mortality; Peripheral arterial disease; Polyvascular disease; Secondary prevention

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; ANTIVITAMIN K; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AMPUTATION; ANGINA PECTORIS; ARTERY DISEASE; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY OBSTRUCTION; CLINICAL TRIAL; DIABETES MELLITUS; FEMALE; HEART INFARCTION; HUMAN; HYPERLIPIDEMIA; HYPERLIPOPROTEINEMIA; HYPERTENSION; INCIDENCE; INTERMITTENT CLAUDICATION; LIMB ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MORTALITY; OUTCOME ASSESSMENT; REVASCULARIZATION; SECONDARY PREVENTION; STROKE;

ADULT; AGED; AMPUTATION; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; COMORBIDITY; DISEASE PROGRESSION; FEMALE; HUMANS; INTERMITTENT CLAUDICATION; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; PROSPECTIVE STUDIES; RECURRENCE; SECONDARY PREVENTION; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 73149111027     PISSN: 03011526     EISSN: None     Source Type: Journal    
DOI: 10.1024/0301-1526.38.4.346     Document Type: Article

References (27)

1. Aquino R, Johnnides C, Makaroun M, Whittle JC, Muluk VS, Kelley ME, Muluk SC. Natural history of claudication: longterm serial follow-up study of 1244 claudicants. J Vasc Surg 2001; 34: 962-70.
2. Barrows RJ, Krumsdorf U, Zankl A, Katus H, Tiefenbacher CP. Significance of close surveillance of patients with peripheral arterial disease. Angiology 2008; Sep 30. [doi:10.1177/0003319708322923 Epub].
3. Brevetti G, Oliva G, Giugliano G, Schiano V, De Maio JI, Chiariello M. Mortality in peripheral arterial disease: a comparison of patients managed by vascular specialists and general practitioners. J Gen Intern Med 2007; 22: 639-44.
4. Brevetti G, Silvestro A, Schiano V, Chiariello M. Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: additive value of flow-mediated dilation to ankle-brachial pressure index. Circulation 2003; 108: 2093-8.
5. Criqui MH, Langer RD, Fronek A, Feigelson HS, Klauber MR, McCann TJ, Browner D. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992; 326: 381-6.
6. Dalager S, Paaske WP, Kristensen IB, Laurberg JM, Falk E. Arteryrelated differences in atherosclerosis expression: implications for atherogenesis and dynamics in intima-media thickness. Stroke 2007; 38: 2698-705.
7. Diehm C, Lange S, Darius H, Pittrow D, von Stritzky B, Te pohl G, Haberl RL, Allenberg JR, Dasch B, Trampisch HJ. Association of low ankle brachial index with high mortality in primary care. Eur Heart J 2006; 14: 1743-9.
8. Dormandy J, Heeck L, Vig S. The natural history of claudication: risk to life and limb. Semin Vasc Surg 1999; 12: 123-37.
9. Ferrières J, Cambou JP, Gayet JL, Herrmann MA, Leizorovicz A. Prognosis of patients with atherothrombotic disease: a prospective survey in a non-hospital setting. Int J Cardiol 2006; 112: 302-7.
10. Fiotti N, Altamura N, Cappelli C, Schillan M, Guarnieri G, Giansante C. Long term prognosis in patients with peripheral arterial disease treated with antiplatelet agents. Eur J Vasc Endovasc Surg 2003; 26: 374-80.
11. Hecht SS. Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention. Lancet Oncol 2002; 3: 461-9.
12. Heuberger BM, Diehm N, Husmann M, Kalka Ch, Baumgartner I. Female patients with atherosclerotic lesions of the lower limbs. Not all are alike. Vasa 2007; 36: 205-9.
13. Jelnes R, Gaardsting O, Hougaard Jensen K, Baekgaard N, Tønnesen KH, Schroeder T. Fate in intermittent claudication: outcome and risk factors. Br Med J (Clin Res Ed) 1986; 293: 1137-40.
14. Kenfield SA, Stampfer MJ, Rosner BA, Colditz GA. Smoking and smoking cessation in relation to mortality in women. JAMA 2008; 299: 2037-47.
15. Leng GC, Lee AJ, Fowkes FG, Whiteman M, Dunbar J, Housley E, Ruckley CV. Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. Int J Epidemiol 1996; 25: 1172-81.
16. Minar E. Peripheral arterial occlusive disease. Vasa 2007; 36: 155-64.
17. Monreal M, Alvarez L, Vila seca B, Coll R, Suárez C, Toril J, Sanclemente C; FRENA Investigators. Clinical outcome in patients with peripheral artery disease. Results from a prospective registry (FRENA). Eur J Intern Med 2008; 19: 192-7.
18. Moyna NM, Thompson PD. The effect of physical activity on endothelial function in man. Acta Physiol Scand 2004; 180: 113-23.
19. Muluk SC, Muluk VS, Kelley ME, Whittle JC, Tierney JA, Webster MW, Makaroun MS. Outcome events in patients with claudication: a 15-year study in 2777 patients. J Vasc Surg 2001; 33: 251-8.
20. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG; TASC II Working Group, Bell K, Caporusso J, Durand-Zaleski I, Komori K, Lammer J, Liapis C, Novo S, Razavi M, Robbs J, Schaper N, Shigematsu H, Sapoval M, White C, White J, Clement D, Creager M, Jaff M, Mohler E 3rd, Rutherford RB, Sheehan P, Sillesen H, Rosenfield K. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg 2007; 33 Suppl 1: S1-75.
21. Pasqualini L, Schillaci G, Vaudo G, Innocente S, Ciuffetti G, Mannarino E. Predictors of overall and cardiovascular mortality in peripheral arterial disease. Am J Cardiol 2001; 88: 1057-60.
22. Slevin M, Wang Q, Font MA, Luque A, Juan-Babot O, Gaffney J, Kumar P, Kumar S, Badimon L, Krupinski J. Atherothrombosis and plaque heterology: different location or a unique disease? Pathobiology 2008; 75: 209-25.
23. Steg PG, Bhatt DL, Wilson PW, D'Agostino R Sr, Ohman EM, Röther J, Liau CS, Hirsch AT, Mas JL, Ikeda Y, Pencina MJ, Goto S; REACH Registry Investigators. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA 2007; 297: 1197-206.
24. Taute BM, Taute R, Heins S, Behrmann C, Podhaisky H. Hyperhomocysteinemia - marker of systemic atherosclerosis in peripheral arterial disease. Int Angiol 2004; 23: 35-40.
25. Taute BM, Taute R, Podhaisky H. Cardiovascular risk assessment in arteriosclerotic peripheral arterial disease. J Pharmakol Ther 2003; 12: 171-7.
26. Vickrey BG, Rector TS, Wickstrom SL, Guzy PM, Sloss EM, Gorelick PB, Garber S, McCaffrey DF, Dake MD, Levin RA. Occurrence of secondary ischemic events among persons with atherosclerotic vascular disease. Stroke 2002; 33: 901-6.
27. Weiss N, Bergert H. Structured surveillance of patients with peripheral arterial occlusive disease after peripheral vascular interventions. Vasa 2009; 38: 302-15.